Chapter 4. Current Pharmacological Targets

  1. John Kelly

Published Online: 13 NOV 2009

DOI: 10.1002/9780470682920.ch4

Principles of CNS Drug Development: From Test Tube to Patient

Principles of CNS Drug Development: From Test Tube to Patient

How to Cite

Kelly, J. (2010) Current Pharmacological Targets, in Principles of CNS Drug Development: From Test Tube to Patient, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470682920.ch4

Author Information

  1. Department of Pharmacology and Therapeutics, National University of Ireland, Galway, Ireland

Publication History

  1. Published Online: 13 NOV 2009
  2. Published Print: 8 JAN 2010

ISBN Information

Print ISBN: 9780470519790

Online ISBN: 9780470682920



  • current pharmacological targets;
  • pharmacological treatments for depression;
  • pharmacological treatments for schizophrenia;
  • anxiety disorders and pharmacological treatments;
  • epilepsy and pharmacological treatments;
  • Parkinson's disease and pharmacological treatments;
  • pharmacological treatments for Alzheimer's disease;
  • psychoactive substance use in ancient times;
  • cholinergic hypothesis of Alzheimer's disease;
  • CNS drugs - prescribing drugs to treat Alzheimer's disease


This chapter contains sections titled:

  • Introduction

  • Pharmacological treatments for depression

  • Pharmacological treatments for schizophrenia

  • Pharmacological treatments for anxiety disorders

  • Pharmacological treatments for epilepsy

  • Pharmacological treatments for Parkinson's disease

  • Pharmacological treatments for Alzheimer's disease

  • Concluding comments

  • References